Oxide (6521.T) Stock Price

OXIDE Corp. generates revenue through the development, manufacture, and sale of electronic components across multiple segments. The Optical segment produces single crystals, optical components, laser light sources, and optical measuring devices for equipment manufacturers and optical product manufacturers. Scintillator single crystals are utilized in positron emission tomography (PET) testing equipment for cancer diagnosis, while laser light sources are integrated into quality inspection devices for silicon wafers in semiconductor manufacturing. Products are primarily sold to companies in the optical measurement, semiconductor, and healthcare sectors. The company's revenue streams are derived from three core business areas: optical measurement, semiconductor, and healthcare. Equipment manufacturers and optical product manufacturers purchase optical components and devices, while semiconductor companies use laser light sources for wafer quality inspection. Healthcare providers rely on scintillator single crystals for PET testing equipment. These segments collectively drive the company's sales and market presence. OXIDE Corp. focuses on supplying specialized components to industries requiring precision optical solutions. The Optical segment's products serve as critical inputs for medical diagnostics and semiconductor production, ensuring consistent demand from established industry players. Sales are concentrated among equipment manufacturers, optical product manufacturers, semiconductor companies, and healthcare providers within the specified business fields.